Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients (vol 33, pg 1745, 2017)

被引：1
|
作者：
Deitelzweig, S.
Luo, X.
Gupta, K.
Trocio, J.
Mardekian, J.
Curtice, T.
Lingohr-Smith, M.
Menges, B.
Lin, J.
机构：
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2018年 / 34卷 / 01期
关键词：
D O I：
10.1080/03007995.2017.1397989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [31] A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants
    Cohen, A. T.
    Hill, N. R.
    Luo, X.
    Masseria, C.
    Abariga, S. A.
    Ashaye, A. O.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 269 : 174 - 181
  • [32] Cost-Effectiveness of Apixaban vs. Other New Oral Anticoagulants for the Prevention of Stroke: An Analysis on Patients with Non-Valvular Atrial Fibrillation in the Greek Healthcare Setting
    Athanasakis, Kostas
    Karampli, Eleftheria
    Tsounis, Dimitrios
    Bilitou, Aikaterini
    Kyriopoulos, John
    CLINICAL DRUG INVESTIGATION, 2015, 35 (11) : 693 - 705
  • [33] Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation
    Huybrechts, Krista F.
    Gopalakrishnan, Chandrasekar
    Bartels, Dorothee B.
    Zint, Kristina
    Gurusamy, Venkatesh K.
    Landon, Joan
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1405 - 1419
  • [34] Cost-Effectiveness of Apixaban vs. Other New Oral Anticoagulants for the Prevention of Stroke: An Analysis on Patients with Non-Valvular Atrial Fibrillation in the Greek Healthcare Setting
    Kostas Athanasakis
    Eleftheria Karampli
    Dimitrios Tsounis
    Aikaterini Bilitou
    John Kyriopoulos
    Clinical Drug Investigation, 2015, 35 : 693 - 705
  • [35] Safety and Effectiveness of Rivaroxaban Among Japanese Elderly Patients With Nonvalvular Atrial Fibrillation in Everyday Clinical Practice
    Kitazono, Takanari
    Ikeda, Takanori
    Ogawa, Satoshi
    Nakagawara, Jyoji
    Minematsu, Kazuo
    Miyamoto, Susumu
    Murakawa, Yuji
    Kidani, Yoko
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Ohashi, Yohei
    Sakaguchi, Toshiaki
    Yamamoto, Noriyuki
    Yamanaka, Satoshi
    STROKE, 2019, 50
  • [36] Direct Oral Anticoagulants: An Updated Systematic Review of Their Clinical Pharmacology and Clinical Effectiveness and Safety in Patients With Nonvalvular Atrial Fibrillation
    Bortman, Lucia Victoria
    Mitchell, Florencia
    Naveiro, Sofia
    Morales, Juana Perez
    Gonzalez, Claudio Daniel
    Di Girolamo, Guillermo
    Giorgi, Mariano Anibal
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (04): : 383 - 396
  • [37] New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
    Mani, Helen
    Lindhoff-Last, Edelgard
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 789 - 798
  • [38] Cost-Effectiveness of Apixaban Compared to Other New Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation
    Rudakova, A. V.
    Tatarskiy, B. A.
    KARDIOLOGIYA, 2014, 54 (07) : 43 - 52
  • [39] Cost-effectiveness of apixaban against other novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation patients
    Lip, G. H. Y.
    Kongnakorn, T.
    Phatak, H.
    Kuznik, A.
    Rublee, D.
    Lanitis, T.
    Liu, L.
    Iloeje, U.
    Dorian, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 54 - 54
  • [40] Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy
    Lip, Gregory Y. H.
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Klem, Christian
    Rosenblatt, Lisa
    Mardekian, Jack
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 405 - 414
12345